A Clinical Study of TQH2929 Injection in Treatment With Generalized Pustular Psoriasis (GPP)
Clinical trial NCT06433531 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06433531
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-19
- Primary completion
- 2025-07-08
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.